June Deals - A Quiet Month For Medtech
June saw sparse dealmaking activity in the pure device/diagnostics sectors, with much more spent in the medical software segment instead. Have a look below at this month's Medtech Insight dealmaking highlights, as well as a table of deals recorded by Biomedtracker that shows less than $700m was spent on pure device/diagnostics deals.
You may also be interested in...
In this month’s Digital Health roundup, Medtech Insight’s Reed Miller talks about iRhythm and Withings’ smartwatches business, Barnaby Pickering reviews digital therapeutics Pear Therapeutics’ restructuring, and Marion Webb presents highlights from her new series on Agetech.
The companies will link Abbott’s blood glucose monitoring devices to WeightWatchers’ smartphone apps and weight loss program.
Medtech Insight's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics and Medical Devices – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in July 2022. Data provided by Biomedtracker.